Developmental toxicity evaluation of berberine in rats and mice

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 77, Issue 3, 2006, Pages 195-206

  Jahnke, Gloria D ^a,c   Price, Catherine J ^b   Marr, Melissa C ^b   Myers, Christina B ^b   George, Julia D ^b  

^a Sciences International Inc   (United States)

^b RTI INTERNATIONAL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Berberine; Birth defects; Development; Herbal remedy; Mice; Pregnancy; Rats

Indexed keywords

ALKALOID; BERBERINE;

ADOLESCENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BIRTH DEFECT; DEVELOPMENTAL DISORDER; DEVELOPMENTAL TOXICITY; DRUG SURVEILLANCE PROGRAM; FEEDING; FEMALE; FETUS; FETUS WEIGHT; FLUID INTAKE; HERBAL MEDICINE; INGESTION; LITTER SIZE; LOWEST OBSERVED ADVERSE EFFECT LEVEL; MATERNAL MORTALITY; MATERNAL WEIGHT GAIN; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; TEA; WEIGHT GAIN;

ANIMALS; ANIMALS, OUTBRED STRAINS; BERBERINE; EMBRYONIC DEVELOPMENT; FEEDING BEHAVIOR; FEMALE; FETAL WEIGHT; FETUS; MICE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PREGNANCY; RATS;

ANIMALIA; HYDRASTIS CANADENSIS;

EID: 33745461309     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20075     Document Type: Article

References (60)

1. Agresti A. 1990. Categorical data analysis. New York: John Wiley & Sons.
2. Armitage P. 1955. Test for linear trends in proportions and frequencies. Biometrics 11:375-386.
3. Bateman J, Chapman RD, Simpson D. 1998. Possible toxicity of herbal remedies. Scot Med J 43:7-15.
4. Bergner P. 1997a. Goldenseal substitutes. Medical herbalist: a journal for the clinical practitioner 8(4). Online version, http://www.medherb. com/84.HTM. Accessed December 22, 1998.
5. Bergner P. 1997b. Goldenseal and the common cold: the antibiotic myth. Medical herbalist: a journal for the clinical practitioner 8(4). Online version, http://www.medherb.com/84.HTM. Accessed December 22, 1998.
6. Bhide MB, Chauvin SR, Data NK. 1969. Absorption, distribution and excretion of berberine. Indian J Med Res 57:2128-2131.
7. Birdsall TC, Kelly GS. 1998. Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Online abstract, http://www.thorne. com/altmedrev/berb-ab2-2.html. Accessed December 22, 1998.
8. Chan E. 1993. Displacement of bilirubin from albumin by berberine. Biol Neonate 63:201-208.
9. Chan TKY. 1994. The prevalence, use, and harmful potential of some Chinese herbal medicines in babies and children. Vet Human Toxicol 36:238-240.
10. Chopra RN, Dished BB, Chowhan JS. 1932. Pharmacological action of berberine. Indian J Med Res XIX:1193-1203.
11. Choudry VP, Sabir M, Bhide VN. 1972. Berberine in giardiasis. Indian Pediatr IX:143-146.
12. 2 tests. Biometrics 10:417-451.
13. Danneman PJ, Mandrell TD. 1997. Evaluation of five agents/methods for anesthesia of neonatal rodents. Lab Anim Sci 47:386-395.
14. Dunnett CW. 1955. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096-1121.
15. Dunnett CW. 1964. New tables for multiple comparisons with a control. Biometrics 20:482-491.
16. Fritz H, Grauwiler J, Hummler H, Lindt S, Schon H. 1978. Collection of control data from teratological experiments in mice, rats, and rabbits. Arzneimittelforschung 28:1410-1413.
17. Ghosh AK, Rakshit MM, Ghosh DK. 1983. Effect of berberine chloride on Leshmania donovani. Indian J Med Res 78:407-416.
18. Gupta S. 1975. Use of berberine in treatment of giardiasis. Am J Dis Child 129:866.
19. Hafez ESE. 1970. Reproduction and breeding techniques for laboratory animals. Philadelphia: Lea & Febiger.
20. Huang W. 1990. Ventricular tachycardias treated with berberine. Zhonghua Xin Xue Guan Bing Za Zhi 18:155-156, 190.
21. Jonckheere AR. 1954. A distribution-free k-sample test against ordered alternatives. Biometrika 41:133-145.
22. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang J-D. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Med 10:1344-1351.
23. Lumb WV, Jones EW. 1973. Anesthesia in laboratory and zoo animals. In: Veterinary anesthesia. Chapter 18. Philadelphia: Lea & Febiger. p 452-453.
24. Marin-Neto JA, Maciel BC, Seeches AL, Gallo L Jr. 1988. Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol 44:253-260.
25. Marr MC, Myers, CB, George JD, Price CJ. 1988. Comparison of single and double staining for evaluation of skeletal development: the effects of ethylene glycol (EG) in CD rats. Teratology 37:476.
26. Newall CA, Anderson LA, Phillipson JD. 1996. Goldenseal. In: Herbal medicines, a guide for health professionals. London: The Pharmaceutical Press. 151p.
27. National Toxicology Program. 1998. Report and study status database: berberine (CAS No. 2086-83-1). National Toxicology Program home page: http://ntp-server.niehs.nih.gov. Accessed December 22, 1998.
28. National Toxicology Program. 2003a. Developmental toxicity screen for berberine chloride dihydrate (CAS No. 5956-60-5) administered in the feed to Swiss (CD-1) mice on gestational days 6 to 17. NTP Study No. TRP-99-005.
29. National Toxicology Program. 2003b. Developmental toxicity evaluation of berberine chloride dihydrate (CAS No. 5956-60-5) administered in the feed to Swiss (CD-1) mice on gestational days 6 to 17. NTP Study No. TER-99-002, NTIS PB2003-105486 (Laboratory Supplement PB2003-105487) April 14, 2003.
30. National Toxicology Program. 2003c. Developmental toxicity screen for berberine chloride dihydrate (CAS No. 5956-60-5) administered in the feed to Sprague-Dawley (CD) rats on gestational days 6 to 20. NTP Study No. TRP-99-004.
31. National Toxicology Program 2003d. Developmental toxicity evaluation for berberine chloride dihydrate (CAS No. 5956-60-5) administered in the feed to Sprague-Dawley (CD) rats on gestational days 6 to 20. NTP Study No. TER-98-008, NTIS PB2003-105484 (Laboratory Supplement PB2003-105485) April 14, 2003.
32. National Toxicology Program 2003e. Developmental toxicity research evaluation of berberine chloride dihydrate (CAS No. 5956-60-5) administered by gavage to Swiss (CD-1) mice on gestational days 6 through 16. NTP Study No. TER-20-103, NTIS PB2003-10341 (Laboratory Supplement PB2003-103042) February 26, 2003.
33. National Toxicology Program 2002. Developmental toxicity research evaluation for berberine chloride dihydrate (CAS No. 5956-60-5) administered by gavage to Sprague Dawley (CD) rats on gestational days 6 through 19. NTP Study No. TER-20-102; NTIS PB2003-101295 (Laboratory Supplement PB2003-101296) Otober 23, 2002.
34. O'Hara M, Kiefer D, Farrell K, Kemper K. 1998. A review of 12 commonly used medicinal herbs. Arch Fam Med 7:523-535.
35. Palmer AK. 1972. Sporadic malformations in laboratory animals and their influence on drug testing. In: Klingsberg MA, Abramovici A, Chemke J. editors. Drugs and fetal development; proceedings. Adv Exp Med Biol 27:45-60.
36. Perraud J. 1976. Levels of spontaneous malformations in the CD rat and the CD-1 mouse. Lab Anim Sci 26:293-300.
37. Purohit SK, Kochar DK, Lal BB, Jatkar PR. 1982. Cultivation of Leshmania tropica from untreated and treated cases of oriental sore. Indian J Public Health XXVI:34-37.
38. Rabbani GH, Butler T Knight J, Sanyal SC, Alam K. 1987. Randomized controlled trial of berberine Sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibro cholerae. J Infect Dis 155:979-984.
39. Registry of the Toxic Effects of Chemical Substances. 1998. Berberine. RTECS database: DR987000. Accessed December 22, 1998.
40. Sabir M, Mahajan VM, Mohapatra LN, Bhide NK. 1976. Experimental study of the antitrachoma action of berberine. Indian J Med Res 64:1160-1167.
41. Salewski E. 1964. Farbemethode zum makroskopischen Nachweis von Implantationsstellen am Uterus der Ratte. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 247:367.
42. SAS Institute Inc. 1989a. SAS language and procedures: usage. Version 6. 1st Edition. Cary, NC: SAS Institute, Inc. 638p.
43. SAS Institute Inc. 1989b. SAS/STAT user's guide. Version 6. 4th Edition. Vois. 1 and 2. Cary, NC: SAS Institute Inc. 1686p.
44. SAS Institute Inc. 1990a. SAS language: reference. Version 6. 1st Edition. Cary, NC: SAS Institute, Inc. 1042p.
45. SAS Institute Inc. 1990b. SAS language: procedures guide. Version 6. 3rd Edition. Cary, NC: SAS Insutute, Inc. 705p.
46. SAS Institute Inc. 1990c. SAS companion for the VMS™ environment. Version 6. 1st Edition. Cary, NC: SAS Institute, Inc. 457p.
47. SAS Institute Inc. 1992. SAS technical report P-229, SAS/STAT software: changes and enhancements. Release 6.07. Cary, NC: SAS Institute, Inc. 620p.
48. SAS Institute Inc. 1996. SAS Companion for the Microsoft Windows environment. Cary, NC: SAS Institute Inc. 302p.
49. SAS Institute Inc. 1997. SAS/STAT software: changes and enhancements. Release 6.12. Cary, NC: SAS Institute, Inc. 1167p.
50. Siegel S. 1956. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill Book Co.
51. Snedecor GW, Cochran WG. 1967. Statistical methods. 6th Edition. Ames, IA: Iowa State University Press.
52. Staples RE. 1974. Detection of visceral alterations in mammalian fetuses. Teratology 9:A37-A38.
53. Stuckhardt JL, Poppe SM. 1984. Fresh visceral examination of rat and rabbit fetuses used in teratogenicity testing. Teratogen Carcinogen Mutagen 4:181-188.
54. Schmeller T, Latz-Brüning B, Wink M. 1997. Biochemical activities of berberine, palmitin and sanguinarine mediating chemical defense against microorganisms and herbivores. Phytochemistry 44:257-266.
55. Sun D, Abraham SN, Beachey EH. 1988. Influence of berberine sulfate on synthesis and expression of pap fimbrial adhesion in uropathic Escherichia coli. Antimicrob Agents Chemother 32:1274-1277.
56. The Merck Index. 1983. Berberine. In: Windholz M, editor. Rahway, NJ: Merck & Co., Inc. p 1167.
57. Vennerstrom JL, Lovelace JK, Waits VB, Hanson, WL, Klayman DL. 1990. Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother 34:918-921.
58. Wilson JG. 1965. Embryological considerations in teratology. In: Wilson JG, Warkany J. editors. Teratology: principals and techniques. Chicago, IL: University of Chicago Press, p 251-277.
59. Winer BJ. 1962. Statistical principles in experimental design. New York: McGraw Hill Book Company.
60. Wixson SK, Smiler KL. 1997. Anesthesia and analgesia in rodents. In: Kohn DF, Wixson SK, White WJ, Benson GJ, editors. Anesthesia and analgesia in laboratory animals. American College of Laboratory Animal Medicine Series. Chapter 9. New York: Academic Press. p 165-203.